NantKwest, Inc. Intellectual Property Contracts & Agreements
12 Contracts & Agreements
- License Agreements (12 contracts)
- Second Amendment to Facility License Agreement, effective as of May 1, 2022, by and between NantWorks, LLC, the Licensor, and ImmunityBio, Inc., the Licensee (Filed With SEC on August 8, 2022)
- Exclusive License Agreement, dated August 7, 2020, by and between ImmunityBio, Inc. and iosBio Ltd (Filed With SEC on January 19, 2021)
- Exclusive License Agreement, dated January 1, 2020, by and between ImmunityBio, Inc. and GlobeImmune, Inc (Filed With SEC on January 19, 2021)
- Exclusive License Agreement, dated February 16, 2016, by and between NantBioScience, Inc. and Etubics Corporation (Filed With SEC on January 19, 2021)
- First Amendment to Facility License Agreement by and between NantWorks, LLC and NantKwest, Inc., dated September 14, 2020 (Filed With SEC on November 9, 2020)
- FACILITY LICENSE AGREEMENT (Filed With SEC on March 30, 2016)
- RUSH- ZELLERX LICENSE AGREEMENT (Filed With SEC on July 27, 2015)
- JOINTDEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on July 27, 2015)
- RUSH- ZELLERX LICENSE AGREEMENT (Filed With SEC on June 19, 2015)
- UHN- ZelleRx LICENSE AGREEMENT (Filed With SEC on June 19, 2015)
- LICENSE AGREEMENT BY AND BETWEEN CONKWEST, INC. AND INTREXON CORPORATION February 23, 2010 Table of Contents (Filed With SEC on June 19, 2015)
- JOINTDEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on June 19, 2015)
